Recent Articles from Business Wire

Amcor plc (“Amcor”) (NYSE: AMCR, ASX: AMC) and Berry Global Group, Inc. (“Berry”) (NYSE: BERY) today announced the European Commission (EC) has granted unconditional approval under the EU Merger Regulation for the previously announced combination of the two companies, satisfying the final regulatory clearance required. In accordance with the merger agreement, this enables the companies to complete the remaining steps towards closing. The transaction is expected to close on April 30, 2025, subject to the satisfaction or waiver of certain other closing conditions.

Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a global provider of space-based data, analytics and space services, completed the previously announced sale of its maritime business to Kpler for approximately $233.5 million, before adjustments, plus a $7.5 million agreement for services over a twelve-month period, post close. Spire used the proceeds of the sale to retire all outstanding debt. The remaining proceeds will be used to invest in near-term growth opportunities.

Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY” or the “Company”), a leading provider of integrated payment processing solutions, today announced that Tim Murphy will be stepping down from his role as Chief Financial Officer to pursue an opportunity outside of the payments industry with a private equity-backed company. Mr. Murphy has served as the Chief Financial Officer of REPAY since 2014, and helped guide the company to its successful public listing in 2019 while also completing eleven acquisitions during his tenure. Mr. Murphy will remain with the Company until May 15, 2025 to help facilitate a smooth transition. Upon his departure from the Company, Thomas Sullivan will be appointed as Interim Chief Financial Officer until a permanent replacement can be identified. Mr. Sullivan is currently the Company’s Chief Accounting Officer.

Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 24, 2025, the Compensation Committee of Cardlytics’ Board of Directors granted an aggregate of 124,050 restricted stock units of Cardlytics to 11 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to five new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and issued on April 21, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4).

Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Denmark Sausage Co. dba Denmark Foods/Arizona Fresh to Premium Brands. The acquisition closed March 3, 2025.

The Avangrid Foundation, the philanthropic arm of leading energy company Avangrid Inc., a member of the Iberdrola Group, and Central Maine Power (CMP) joined Kennebec Valley Community College (KVCC) in a ribbon-cutting ceremony for their Electrical Lineworker Technology Program. KVCC unveiled their new Derrick Digger Truck, a state-of-the-art addition to the program’s training resources.

PENN Entertainment, Inc. (“PENN” or the “Company”) (Nasdaq: PENN) today announced that it intends to nominate Johnny Hartnett and Carlos Ruisanchez for election to its Board of Directors following discussions with HG Vora Capital Management, LLC (“HG Vora”). Ron Naples has informed the Board that he will retire from the Board, effective immediately. Barbara Shattuck Kohn and Saul Reibstein have notified the Company that they will not stand for reelection at the 2025 Annual Meeting of Shareholders. The Board now comprises eight directors, seven of whom are independent.

Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed field ablation (PFA) device—the Globe PF System. These pivotal findings from the PULSAR IDE study were announced at the Heart Rhythm Society (HRS) meeting in San Diego1, highlighting the safety and efficacy data of the Globe PF System, which is currently under PMA review with the US FDA.

BancPlus Corporation, the holding company for BankPlus, today announced that on April 24, 2025, its Board of Directors declared a quarterly cash dividend of $0.50 per share of its common stock. The cash dividend is equivalent to an annualized dividend of $2.00 per share. The cash dividend will be paid on June 13, 2025, to shareholders of record as of the close of business on May 15, 2025.

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today noted that Akeso, Inc. (Akeso, HKEX Code: 9926.HK) announced that ivonescimab was approved by the Chinese Health Authorities, the National Medical Products Administration (NMPA), for a second indication based on the results of the Phase III clinical trial, HARMONi-2 or AK112-303. HARMONi-2 evaluated monotherapy ivonescimab against monotherapy pembrolizumab in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have positive PD-L1 expression. HARMONi-2 is a single region, multi-center, Phase III study conducted in China sponsored by Akeso with all relevant data exclusively generated, managed, and analyzed by Akeso.

Lubrizol has secured a distribution partnership with Palmer Holland, Inc. to expand availability of our innovative ingredient solutions for the nutraceutical, dietary supplement, food and beverage market segments across the Northeastern US region.

AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “aa” (Superior) of Principal Life Insurance Company and Principal National Life Insurance Company. Both are life insurance operating companies of Principal Financial Group, Inc. (PFG) [NASDAQ: PFG] and collectively referred to as Principal. Concurrently, AM Best has affirmed the Long-Term ICRs of “a” (Excellent) of Principal Financial Services, Inc. and PFG, as well as the group’s Long-Term Issue Credit Ratings (Long-Term IRs). In addition, AM Best has affirmed the group’s Short-Term Issue Credit Rating (Short-Term IR). The outlook of these Credit Ratings (ratings) is stable. (Please see below for a detailed listing of the Long- and Short-Term IRs.) All companies are headquartered in Des Moines, IA.

Latino Community Foundation:

Hippocratic AI, the company that pioneered the first safety-focused generative AI healthcare agents, announced today that it is recognized as one of America’s Greatest Startup Workplaces 2025 by Newsweek and Plant-A Insights Group. Newsweek and Plant-A Insights Group recognized startups for their excellence in workplace culture and sustainable growth through a rigorous evaluation that analyzed publicly available data and utilized multiple third-party data platforms to gather performance indicators that provide insights into employee experience and the company’s sustainability and growth since its inception.

Commerce Bancshares, Inc. (NASDAQ: CBSH) announced today that its Board of Directors declared a quarterly dividend of $0.275 per share on the Company's common stock. The dividend is payable on June 24, 2025 to stockholders of record at the close of business on June 6, 2025.

Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, presented new data at the World Vaccine Congress 2025 on LHNVD-303, the company's composite peptide vaccine for sepsis due to bacterial infections and its applications in inflammatory diseases. The World Vaccine Congress took place in Washington, D.C. from April 22-24.

AM Best has removed from under review with negative implications and downgraded the Financial Strength Rating to B++ (Good) from A- (Excellent) and the Long-Term Issuer Credit Ratings to “bbb” (Good) from “a-” (Excellent) of Oregon Mutual Insurance Company and Western Protectors Insurance Company, which are domiciled in McMinnville, OR and collectively referred to as Oregon Mutual Group. The outlooks assigned to these Credit Ratings (ratings) is stable.

Bragg Gaming Group (NASDAQ: BRAG, TSX: BRAG) (“Bragg” or the “Company”), a leading global B2B iGaming content and technology provider, today announced it has reached an agreement with its lenders, certain entities controlled by Doug Fallon, to repay USD 5 million of its outstanding USD 7 million secured promissory note and to extend the maturity of the remaining USD 2 million until June 6, 2025 (the “Note”).

This week, XPRIZE announced that Mati Carbon, a graduate of the AirMiners Launchpad accelerator program, as the winner of the $50M grand prize in the XPRIZE Carbon Removal competition, the largest single incentive ever offered for climate innovation. The prize recognizes Mati Carbon’s enhanced rock weathering process, which converts atmospheric carbon dioxide into stable minerals while improving smallholder farmers’ yields and enhancing their livelihoods.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) will present new data from studies evaluating two of its internally developed, next-generation, investigational oncology therapies that it has global rights to, ZL-6201, a novel leucine-rich repeat-containing protein 15 (LRRC15) antibody-drug conjugate (ADC) targeting multiple solid tumors, and ZL-1222, an innovative anti-PD-1/ interleukin-12 (IL-12) immunocytokine for cancer immunotherapy, during poster sessions at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, Illinois this week. The data provide strong evidence supporting continued evaluation of both investigational therapies.

Reproductive Partners Medical Group (RPMG), a leading fertility clinic in Southern California and proud member of the Ivy Fertility network, has been honored with two city proclamations, from Beverly Hills and Westminster, recognizing National Infertility Awareness Week (NIAW). This recognition shines a spotlight on the impact of infertility and the need for increased awareness, support, and equitable access to fertility care.

Hyosung Americas, the leading provider of ATMs, urges all ATM owners to immediately implement critical security updates to protect their machines from evolving cyber threats that have affected multiple ATM networks across the industry.

The "Loyalty Programs Market Intelligence and Future Growth Dynamics - 50+ KPIs on Loyalty Programs Trends by End-Use Sectors, Operational KPIs, Retail Product Dynamics, and Consumer Demographics - Q1 2025 Update" report has been added to ResearchAndMarkets.com's offering.

The "Meal Replacement Products Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering.

Agenus Inc. (Nasdaq: AGEN), a clinical-stage immuno-oncology company, today announced updated data from the hepatocellular carcinoma (HCC) cohort of its ongoing Phase 1 study evaluating botensilimab (BOT) in combination with balstilimab (BAL). These findings are being presented at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, Illinois. The HCC cohort comprised patients with difficult-to-treat disease who had progressed following standard treatments, including approved immunotherapies.

Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO).

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the acceptance of four abstracts for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, Illinois.

Talus Bioscience, a technology-enabled therapeutics company, today announced new preclinical data from programs targeting transcription factors in chordoma, non-small cell lung cancer, and advanced prostate cancer. The data, presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting, held April 25-30, support Talus Bio’s first-in-class approach to target previously undruggable transcription factors using regulome-scale discovery in live human cells.

Parabilis Medicines (formerly Fog Pharmaceuticals), a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer, is presenting preclinical data demonstrating first-in-industry targeted degradation of ERG at the 2025 American Association for Cancer Research (AACR) Annual Meeting, which begins today in Chicago, Illinois.

FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today presented new plixorafenib results from the Phase 1/2a clinical trial that demonstrate that circulating tumor DNA (ctDNA) accurately detects BRAF mutations in tumor biopsies and change in variant allele frequency (VAF) of BRAF mutation in ctDNA may be a surrogate marker for monitoring disease. The data is being presented at the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 25-30 in Chicago.

NextPoint Therapeutics, a clinical-stage biotechnology company launching a new world of precision therapeutics through its leading scientific work on the novel B7-H7 axis, today announced it will present compelling data on NPX125, its lead B7-H7-targeting antibody-drug conjugate (ADC) with a proprietary novel linker technology, at the American Association for Research (AACR) Annual Meeting 2025 in Chicago.

CatalYm today announced the presentation of the first preclinical data demonstrating that the company’s clinical-stage antibody visugromab can improve the anti-tumor activity of antibody-drug conjugates (ADCs). The data will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place in Chicago, IL, April 25-30, 2025. The poster will highlight the potential of targeting Growth Differentiation Factor 15 (GDF-15) to enhance the activity and overcome resistance to ADC therapies, which are increasingly used as frontline treatments in several solid tumor indications. The full abstract is available on the AACR Annual Meeting website.

Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the publication of 3 abstracts for poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025. In addition to a trial-in-progress study design update on the ongoing multicenter study Agni-01 (NCT06060613), Obsidian will share preclinical data from our cytoDRiVE® platform demonstrating spatiotemporal regulation of membrane-bound IL12 in syngeneic solid tumor models and preclinical data on OBX-115 TIL phenotype starting from NSCLC tumor tissue.

CDR-Life today announced the presentation of data for its novel T cell engager (TCE) programs at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. The presentations showcase the company's proprietary M-gager® platform-derived TCE candidates, with a focus on CDR404, currently in Phase 1 clinical trials for MAGE-A4-positive solid tumors.

Experian® has been honored with the National Association of State Workforce Agencies (NASWA) Outstanding Performance Award for the second year in a row. The recognition underscores Experian’s dedication to reducing fraud and promoting unemployment insurance (UI) integrity through its effective use of the State Information Data Exchange System (SIDES). The award was presented during NASWA’s annual SIDES Seminar in Salt Lake City.

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines through its powerful computational drug discovery engine, today announced that its Phase 1/2 clinical trial of NDI-219216, the company's investigational non-covalent Werner syndrome helicase (WRN) inhibitor, is actively enrolling and dosing patients with advanced solid tumors.

Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics that harness the ELANE pathway, today announced the presentation of new preclinical data for its lead drug candidate, N17350, at the American Association for Cancer Research® Annual Meeting 2025 (“AACR”). The presentation highlights N17350’s superior and selective tumor-killing ability compared to standard-of-care chemotherapies in ovarian cancer models, including chemotherapy-resistant tumors, derived from patients.

Marcus & Millichap (NYSE:MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of Alamitos West Health & Rehabilitation Center, a 150-licensed bed/142-operating bed skilled nursing facility, and Katella Senior Living, a 73-unit, 77-bed assisted living and memory care facility in Los Alamitos, California. The two properties sold all-cash for $34.5 million.

The Arbor Day Foundation rang the opening bell of the New York Stock Exchange this morning. It’s the third time the tree planting nonprofit has been invited to ring the bell in the last four years.

Lyons & Simmons, LLP co-founders Michael Lyons and Christopher Simmons have been recognized among the top plaintiffs’ tort attorneys for 2025 by D Magazine. Partner P. Wes Black was also selected to the Best Lawyers in Dallas listing for his appellate work.

KBRA assigns preliminary ratings to four classes of notes (the “Notes”) issued by Kapitus Asset Securitization V LLC, Series 2025-1.

The "Connected Commercial Drones - 1st Edition" report has been added to ResearchAndMarkets.com's offering.

Avvio Medical Inc. (formerly Applaud Medical, Inc.) today announced that results from its AEROLITH randomized clinical trial will be presented at the upcoming 2025 American Urological Association (AUA) Annual Meeting, taking place April 26-29 in Las Vegas, Nevada. The AEROLITH study evaluated the safety and effectiveness of Acoustic Enhancer Microbubble Cavitation (AEMC) when used with ureteroscopic laser lithotripsy (URS-LL) to treat kidney and ureteral stones.

An alarming new investigation released by members of the New York Medical Cannabis Industry Association has uncovered that illegal cannabis flower - smuggled in from the West Coast - is being sold in licensed dispensaries across New York State. Lab-verified findings confirm that at least two widely available brands, Heady Tree and Runtz, were not grown in New York and entered the state illegally. Bulk quantities of out-of-state products easily made their way into New York and on to the shelves of legal stores because New York regulators have not implemented a track-and-trace system.

The "Japan Condominiums & Apartments Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.

Sayles Law Firm is pleased to announce that founder Richard A. “Dick” Sayles has been selected to D Magazine’s Best Lawyers in Dallas list for his work in business and commercial litigation. The 2025 edition marks another year of recognition for Mr. Sayles, whose name is synonymous with high-stakes trial success across the state.

For the third year in a row, Eversource Energy (NYSE:ES) has been recognized by USA TODAY and Statista Inc. as one of America’s Climate Leaders for 2025. Ranked #1 among energy companies and utilities nationwide for the highest core emissions reduction year-over-year and ranked #146 overall, this recognition highlights Eversource’s continued achievements in prioritizing sustainability and environmental stewardship across its operations.

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, will present data from an abstract describing the implications of applying the company’s Bladder EpiCheck® urine test as an adjunct to routine surveillance by white light cystoscopy in all high-risk non-muscle invasive bladder cancer (NMIBC) patients at the American Urological Association's (AUA) 2025 Annual Meeting in Las Vegas, Nevada.

Radiant Biotherapeutics, a preclinical biotechnology company developing an antibody platform to deliver first-in-class transformative therapies for patients facing life-changing disease, today announced the presentation of a poster at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025 in Chicago. The presentation describes the company’s Multabody™ platform, a novel approach to stimulating key targets in immunotherapy that have remained out of reach due to toxicity or lack of response.

OKI Circuit Technology (“OTC”; President: Masaya Suzuki; Head office: Tsuruoka City, Yamagata), the OKI Group printed circuit board (PCB) company, has successfully developed 124-layer PCB technology for wafer inspection equipment designed for next-generation high bandwidth memory, such as HBM (Note 1) mounted on AI semiconductors. This is a roughly 15% increase in the number of layers over conventional 108-layer designs. OTC is seeking to establish mass production technology by October 2025 at its Joetsu Plant in Joetsu City, Niigata Prefecture, which has a proven track record and advanced development and production capabilities in the field of high multilayer, high-precision, large-format PCBs for semiconductor inspection equipment.

Adapting some of the nation’s most innovative affordable housing strategies that attract private investment and philanthropy can greatly extend the impact of new Measure A funding to scale up construction and preservation of affordable housing in Los Angeles County, according to initial findings of a study commissioned by the Los Angeles Business Council Institute.

Jeffrey Simon, a founding shareholder of Simon Greenstone Panatier, PC, has been recognized among the 2025 Best Lawyers in Dallas by D Magazine.

Dallas-based family law firm Orsinger, Nelson, Downing & Anderson, LLP, (ONDA) is proud to announce the recognition of three firm partners in D Magazine’s 2025 edition of the Best Lawyers in Dallas.

PAR Technology Corporation (NYSE: PAR) today announced that it will report its first quarter financial results on Friday, May 9, 2025. The results are scheduled to be released at 7:30 a.m. ET, followed by an investor presentation and conference call at 9:00 a.m. ET.

The "Scar Management Market - A Global and Regional Analysis: Focus on Product, Scar Type, End User, and Country Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

The "Singapore Accounting Software Market | Growth, Size, Industry, Analysis, Revenue, Value, Companies, Trends, Share & Forecast: Market Forecast By Component, By Enterprise Size, By Type, By End-use Industry And Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

Alex Brauer, co-founder of the litigation boutique Bailey Brauer PLLC, has been recognized among the 2025 Best Lawyers in Dallas by D Magazine.

AM Best has revised the outlooks to positive from stable and affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a-” (Excellent) of the rated operating subsidiaries of SiriusPoint Ltd. (SiriusPoint) (Bermuda) [NYSE: SPNT]. Additionally, AM Best has affirmed the Long-Term ICR of “bbb-” (Good) of SiriusPoint, which is a non-operating holding company. (See below for a detailed listing of the companies and Credit Ratings [ratings]).

AM Best has upgraded the Long-Term Issuer Credit Rating (Long-Term ICR) to “bbb+” (Good) from “bbb” (Good) and affirmed the Financial Strength Rating (FSR) of B++ (Good) of Unity Financial Life Insurance Company (Unity) (Cincinnati, OH). In addition, AM Best has revised the outlook of the Long-Term ICR to stable from positive. The outlook of the FSR is stable.

The Law Offices of Frank L. Branson is proud to announce that firm founder Frank L. Branson has again been recognized as one of D Magazine’s Best Lawyers in Dallas. This prestigious honor highlights Mr. Branson’s continued excellence in high-stakes personal injury litigation and reinforces his reputation as one of the nation’s most accomplished trial attorneys.

It’s no secret that our waistlines often expand in middle-age, but the problem isn’t strictly cosmetic. Belly fat accelerates aging and slows down metabolism, increasing our risk for developing diabetes, heart problems and other chronic diseases. Exactly how age transforms a six pack into a softer stomach, however, is murky.

i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”), announced today that it will release its financial results for the second quarter ended March 31, 2025, on Thursday, May 8, 2025, after the Nasdaq market close.

FirstHive, industry-leading data activation and AI-powered Customer Data Platform (CDP) solutions, and Infogain, a Silicon Valley-based leader in digital customer experience engineering, today announced a strategic partnership to co-create innovative customer experience solutions for enterprises.

The board of directors of GATX Corporation (NYSE: GATX) today declared a quarterly dividend of $0.61 per common share, payable June 30, 2025, to shareholders of record on June 13, 2025. This quarterly dividend is unchanged from the prior quarter.

University of Phoenix is pleased to announce the release of its new as an extensive resource helping students and prospective students understand the admissions process including degree opportunities, programmatic accreditation, student support services, and ways to reduce education costs. A natural extension of the university’s dynamic and personalized digital campus, the guide is designed to support seamless navigation, enabling students to find what they need and embark on their academic journey with confidence.

Please replace the release dated April 21, 2025 with the following corrected version which updates the date and time for the earnings and conference call.

BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of hundreds to thousands of individual cells, addressing growing demand for scalable, multiomics approaches in single-cell research. By reducing reliance on time consuming cell sorting techniques, such as fluorescence-activated cell sorting (FACS), the workflow offers a more streamlined and accessible approach to comprehensive genomic and transcriptomic profiling.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) and Z Squared Inc. is fair to Coeptis shareholders.

KBRA releases a report examining the stability and transition patterns of our ratings over 1-year, 3-year, 5-year, and lifetime time horizons between 2011 and 2024. The ratings universe used in this study includes both published and unpublished long-term credit ratings (LTCR) assigned across all geographical regions, which are assigned to issuers, transactions, and securities using the same rating scale.

The "Enterprise Tech Ecosystem Series: AIG 2025" company profile has been added to ResearchAndMarkets.com's offering.

The "Vietnam Contract Logistics Market | Industry, Segmentation, Share, Analysis, Forecast, Companies, Outlook, Competitive Landscape, Trends, Value, Growth, Size & Revenue: Market Forecast By End User, By Region And Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

VistaShares, an innovative asset manager seeking to disrupt the status quo in thematic exposures, income investing, and more, is today announcing the April monthly distribution amount for the VistaShares Target 15™ Berkshire Select Income ETF (OMAH).

The "ITMAconnect: Specialists Explore the Textile Industry's Pressing Concerns" report from Textiles Intelligence Ltd. has been added to ResearchAndMarkets.com's offering.

In an effort to "pull back the curtains" and provide insights into the mission of the brothel and connections between clients and courtesans, the world renowned Chicken Ranch has announced the publication of a book - "The World Famous Historic Chicken Ranch: Where the West is Still Wild" which features reviews from clients reflecting on their experiences at the Las Vegas-area brothel.